Clinical Trial Update: Pilot Study of Safety, Tolerability, Pharmacokinetics/Pharmacodynamics of RP103 Compared to Cystagon® in Patients With Cystinosis [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 pilot trial compared RP103 with Cystagon for cystinosis to assess safety, tolerability, and pharmacokinetics/pharmacodynamics, with results posted i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cystinosis

Drugs mentioned

• Cystagon (cysteamine bitartrate)
• RP103

Snippet

Sponsor: Amgen | Conditions: Cystinosis | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2014-10-28